2-(3-Ethoxy-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

1-(4'-Chloro-biphenyl-3-yl)-ethanone, 500mg

(1R,2R,3R,4S,5R,6S,7S,8S)-methyl 4-bromocubane-1-carboxylate, 98%, 1g

4-amino-N-(3,4-dimethylphenyl)benzenesulfonamide, 100mg

(S)-tert-Butyl 1-(4-bromobenzyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

h-his(trt)-oh, 95.0%, 10g

N-(3-(7-(1,3-dimethyl-1H-pyrazol-5-ylamino)-1-methyl-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide, 98%, 10mg

4-(Pyridin-4-yl)-N-(m-tolyl)thiazol-2-amine, 95.0%, 50mg

tert-Butyl (3-bromo-5-iodophenyl)carbamate, 97%, 1g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 750m2/g)25g

1-(2-METHOXYETHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)INDOLINE, 95%, 250mg

4-Amino-5-nitro-2-pyridinol, 95.0%, 250mg

2-Propyl-2 H -pyrazole-3-carboxylic acid, 95.0%, 250mg